Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Rodrigues FB"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 35
Tytuł:
A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study.
Autorzy:
Lipsmeier F; Roche Pharma Research and Early Development, pRED Informatics, Pharmaceutical Sciences, Clinical Pharmacology, and Neuroscience, Ophthalmology, and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Simillion C; Roche Pharma Research and Early Development, pRED Informatics, Pharmaceutical Sciences, Clinical Pharmacology, and Neuroscience, Ophthalmology, and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Bamdadian A; Roche Pharma Research and Early Development, pRED Informatics, Pharmaceutical Sciences, Clinical Pharmacology, and Neuroscience, Ophthalmology, and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Tortelli R; Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Byrne LM; Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Zhang YP; Roche Pharma Research and Early Development, pRED Informatics, Pharmaceutical Sciences, Clinical Pharmacology, and Neuroscience, Ophthalmology, and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Wolf D; Roche Pharma Research and Early Development, pRED Informatics, Pharmaceutical Sciences, Clinical Pharmacology, and Neuroscience, Ophthalmology, and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Smith AV; Ionis Pharmaceuticals Inc, Carlsbad, CA, United States.
Czech C; Roche Pharma Research and Early Development, pRED Informatics, Pharmaceutical Sciences, Clinical Pharmacology, and Neuroscience, Ophthalmology, and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Rare Disease Research Unit, Pfizer, Nice, France.
Gossens C; Roche Pharma Research and Early Development, pRED Informatics, Pharmaceutical Sciences, Clinical Pharmacology, and Neuroscience, Ophthalmology, and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Weydt P; Department of Neurology, University of Ulm Medical Center, Ulm, Germany.; Department of Neurodegenerative Disease and Gerontopsychiatry/Neurology, University of Bonn Medical Center, Bonn, Germany.
Schobel SA; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Rodrigues FB; Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Wild EJ; Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Lindemann M; Roche Pharma Research and Early Development, pRED Informatics, Pharmaceutical Sciences, Clinical Pharmacology, and Neuroscience, Ophthalmology, and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Pokaż więcej
Źródło:
Journal of medical Internet research [J Med Internet Res] 2022 Jun 28; Vol. 24 (6), pp. e32997. Date of Electronic Publication: 2022 Jun 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Huntington Disease*/diagnosis
Huntington Disease*/psychology
Huntington Disease*/therapy
Motor Skills*
Cognition ; Cross-Sectional Studies ; Humans ; Oligonucleotides ; Reproducibility of Results ; Sensitivity and Specificity
Czasopismo naukowe
Pełny tekstSzczegóły
Tytuł:
Huntington's Disease Clinical Trials Corner: April 2022.
Autorzy:
Estevez-Fraga C; Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK.
Rodrigues FB; Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK.; Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Instituto de Medicina Molecular, Lisbon, Portugal.
Tabrizi SJ; Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK.
Wild EJ; Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK.
Pokaż więcej
Źródło:
Journal of Huntington's disease [J Huntingtons Dis] 2022; Vol. 11 (2), pp. 105-118.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Huntington Disease*/drug therapy
Huntington Disease*/therapy
Humans ; Longitudinal Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety and Feasibility of Research Lumbar Puncture in Huntington's Disease: The HDClarity Cohort and Bioresource.
Autorzy:
Rodrigues FB; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK.
Owen G; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK.
Sathe S; CHDI Management/CHDI Foundation, Princeton, NJ, USA.
Pak E; CHDI Management/CHDI Foundation, Princeton, NJ, USA.
Kaur D; CHDI Management/CHDI Foundation, Princeton, NJ, USA.
Ehrhardt AG; CHDI Management/CHDI Foundation, Princeton, NJ, USA.
Lifer S; CHDI Management/CHDI Foundation, Princeton, NJ, USA.
Townhill J; Enroll-HD platform, European Huntington's Disease Network, University Hospital of Ulm, Ulm, Germany.
Schubert K; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK.
Leavitt BR; Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Guttman M; Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Bang J; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Lewerenz J; Department of Neurology, Ulm University, Ulm, Germany.
Levey J; CHDI Management/CHDI Foundation, Princeton, NJ, USA.; Enroll-HD platform, European Huntington's Disease Network, University Hospital of Ulm, Ulm, Germany.
Sampaio C; CHDI Management/CHDI Foundation, Princeton, NJ, USA.
Wild EJ; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK.
Pokaż więcej
Corporate Authors:
HDClarity Investigators
Źródło:
Journal of Huntington's disease [J Huntingtons Dis] 2022; Vol. 11 (1), pp. 59-69.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Huntington Disease*/genetics
Biomarkers ; Feasibility Studies ; Headache/etiology ; Humans ; Spinal Puncture/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Growth and renal function dynamics of renal oncocytomas in patients on active surveillance.
Autorzy:
Neves JB; Division of Surgery and Interventional Science, University College London, London, UK.; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.
Varley R; Department of General Surgery, Manchester University NHS Foundation Trust, London, UK.
Agnesi S; Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
Withington J; Urology Unit, Royal Marsden NHS Foundation Trust, London, UK.
Rodrigues FB; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
Warren H; Department of Urology, King's College Hospital NHS Foundation Trust, London, UK.
Yuminaga Y; Department of Urology, Royal Perth Hospital, Perth, WA, Australia.
Capitanio U; Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
Rode N; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.
Grant L; Department of Radiology, Royal Free London NHS Foundation Trust, London, UK.
Tran-Dang MA; Department of Histopathology, Royal Free London NHS Foundation Trust, London, UK.
El-Sheikh S; Department of Histopathology, Royal Free London NHS Foundation Trust, London, UK.
Walkden M; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK.
Cullen D; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.
Aitchison M; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.
Patki P; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.
Mumtaz F; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.
Barod R; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.
Bex A; Division of Surgery and Interventional Science, University College London, London, UK.; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.
Tran MGB; Division of Surgery and Interventional Science, University College London, London, UK.; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 Dec; Vol. 128 (6), pp. 722-727. Date of Electronic Publication: 2021 Aug 09.
Typ publikacji:
Journal Article
MeSH Terms:
Glomerular Filtration Rate*
Tumor Burden*
Watchful Waiting*
Adenoma, Oxyphilic/*pathology
Adenoma, Oxyphilic/*physiopathology
Kidney Neoplasms/*pathology
Kidney Neoplasms/*physiopathology
Adenoma, Oxyphilic/complications ; Adenoma, Oxyphilic/therapy ; Aged ; Aged, 80 and over ; Cryosurgery ; Female ; Follow-Up Studies ; Humans ; Kidney Neoplasms/complications ; Kidney Neoplasms/therapy ; Male ; Middle Aged ; Nephrectomy ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/physiopathology ; Retrospective Studies ; Survival Rate
SCR Disease Name:
Oncocytoma, renal
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of additional load at different heights on gait initiation: A statistical parametric mapping of center of pressure and center of mass behavior.
Autorzy:
Vieira MF; Bioengineering and Biomechanics Laboratory, Federal University of Goiás, Goiânia, Goiás, Brazil.
Rodrigues FB; Bioengineering and Biomechanics Laboratory, Federal University of Goiás, Goiânia, Goiás, Brazil.; State University of Goiás - Unidade Trindade-GO, Brazil.
de Oliveira Assis A; Bioengineering and Biomechanics Laboratory, Federal University of Goiás, Goiânia, Goiás, Brazil.
de Mendonça Mesquita E; Bioengineering and Biomechanics Laboratory, Federal University of Goiás, Goiânia, Goiás, Brazil.
Lemes TS; Bioengineering and Biomechanics Laboratory, Federal University of Goiás, Goiânia, Goiás, Brazil.
De Villa GAG; Bioengineering and Biomechanics Laboratory, Federal University of Goiás, Goiânia, Goiás, Brazil.
Baptista RR; Pontifical Catholic University Rio Grande do Sul, Porto Alegre, Brazil.
de Oliveira Andrade A; Centre for Innovation and Technology Assessment in Health (NIATS), Federal University of Uberlândia, Uberlândia, Brazil.
Lobo da Costa PH; Physical Education Department, Federal University of São Carlos, São Carlos, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jun 11; Vol. 16 (6), pp. e0242892. Date of Electronic Publication: 2021 Jun 11 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pressure*
Statistics as Topic*
Gait/*physiology
Adult ; Biomechanical Phenomena ; Female ; Humans ; Male ; Weight-Bearing ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's disease.
Autorzy:
Ou ZA; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Byrne LM; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Rodrigues FB; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Tortelli R; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Johnson EB; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Foiani MS; UK Dementia Research Institute at UCL, London, WC1E 6BT, UK.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG, UK.
Arridge M; Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, WC1N 3BG, UK.
De Vita E; Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, WC1N 3BG, UK.; Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, London, SE1 7EH, UK.
Scahill RI; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Heslegrave A; UK Dementia Research Institute at UCL, London, WC1E 6BT, UK.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG, UK.
Zetterberg H; UK Dementia Research Institute at UCL, London, WC1E 6BT, UK.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG, UK.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 80, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 80, Mölndal, Sweden.
Wild EJ; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Feb 10; Vol. 11 (1), pp. 3481. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Brain-Derived Neurotrophic Factor/*blood
Brain-Derived Neurotrophic Factor/*cerebrospinal fluid
Huntington Disease/*blood
Huntington Disease/*cerebrospinal fluid
Adult ; Biomarkers/blood ; Biomarkers/cerebrospinal fluid ; Cohort Studies ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Immunoassay ; Male ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.
Autorzy:
Lowe AJ; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Sjödin S; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Rodrigues FB; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Byrne LM; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Tortelli R; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Zetterberg H; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; UK Dementia Research Institute at UCL, London, United Kingdom.
Wild EJ; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Aug 17; Vol. 15 (8), pp. e0233820. Date of Electronic Publication: 2020 Aug 17 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cerebrospinal Fluid Proteins/*metabolism
Huntington Disease/*cerebrospinal fluid
Adult ; Aged ; Amyloid beta-Protein Precursor/cerebrospinal fluid ; Biomarkers/cerebrospinal fluid ; Case-Control Studies ; Cognition ; Cross-Sectional Studies ; Disease Progression ; Endosomes/metabolism ; Female ; G(M2) Activator Protein/cerebrospinal fluid ; Humans ; Huntingtin Protein/genetics ; Huntington Disease/genetics ; Huntington Disease/psychology ; Linear Models ; Longitudinal Studies ; Lysosomal-Associated Membrane Protein 2/cerebrospinal fluid ; Lysosomal Membrane Proteins/cerebrospinal fluid ; Male ; Mass Spectrometry/methods ; Middle Aged ; Principal Component Analysis ; Prospective Studies ; Proteins/metabolism ; Trinucleotide Repeat Expansion
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effects of triceps surae fatigue and weight training level on gait variability and local stability in young adults.
Autorzy:
Lehnen GCS; Bioengineering and Biomechanics Laboratory, Federal University of Goias, Avenida Esperança s/n, Campus Samambaia, Goiania, Goiás, 74.690-900, Brazil.
Rodrigues FB; Bioengineering and Biomechanics Laboratory, Federal University of Goias, Avenida Esperança s/n, Campus Samambaia, Goiania, Goiás, 74.690-900, Brazil. .; State University of Goias-Campus Trindade, Trindade, GO, 75.386-580, Brazil. .
Galvão JMA; Bioengineering and Biomechanics Laboratory, Federal University of Goias, Avenida Esperança s/n, Campus Samambaia, Goiania, Goiás, 74.690-900, Brazil.
Andrade AO; Centre for Innovation and Technology Assessment in Health, Federal University of Uberlandia, Uberlandia, Brazil.
Vieira MF; Bioengineering and Biomechanics Laboratory, Federal University of Goias, Avenida Esperança s/n, Campus Samambaia, Goiania, Goiás, 74.690-900, Brazil.
Pokaż więcej
Źródło:
Medical & biological engineering & computing [Med Biol Eng Comput] 2020 Aug; Vol. 58 (8), pp. 1791-1802. Date of Electronic Publication: 2020 Jun 05.
Typ publikacji:
Journal Article
MeSH Terms:
Exercise/*physiology
Gait/*physiology
Muscle Fatigue/*physiology
Acceleration ; Accidental Falls ; Adult ; Exercise Test/methods ; Female ; Humans ; Male ; Muscle, Skeletal/physiology ; Postural Balance/physiology ; Resistance Training/methods ; Torso/physiology ; Walking/physiology ; Walking Speed/physiology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Huntington's Disease Clinical Trials Corner: April 2020.
Autorzy:
Rodrigues FB; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, UK.; Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, PT, Portugal.; Instituto de Medicina Molecular, Lisbon, PT, Portugal.
Wild EJ; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, UK.
Pokaż więcej
Źródło:
Journal of Huntington's disease [J Huntingtons Dis] 2020; Vol. 9 (2), pp. 185-197.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Clinical Trials as Topic*
Huntington Disease/*therapy
Genetic Therapy ; Humans ; Huntington Disease/drug therapy ; Randomized Controlled Trials as Topic ; Tetrabenazine/analogs & derivatives ; Tetrabenazine/pharmacology ; Valine/analogs & derivatives ; Valine/pharmacology ; Vesicular Monoamine Transport Proteins/antagonists & inhibitors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Characterizing White Matter in Huntington's Disease.
Autorzy:
Gregory S; University College London Huntington's Disease Centre, Department of Neurodegenerative Disease University College London Queen Square Institute of Neurology, University College London London United Kingdom.
Johnson E; University College London Huntington's Disease Centre, Department of Neurodegenerative Disease University College London Queen Square Institute of Neurology, University College London London United Kingdom.
Byrne LM; University College London Huntington's Disease Centre, Department of Neurodegenerative Disease University College London Queen Square Institute of Neurology, University College London London United Kingdom.
Rodrigues FB; University College London Huntington's Disease Centre, Department of Neurodegenerative Disease University College London Queen Square Institute of Neurology, University College London London United Kingdom.
Henderson A; University College London Huntington's Disease Centre, Department of Neurodegenerative Disease University College London Queen Square Institute of Neurology, University College London London United Kingdom.
Moss J; University College London Huntington's Disease Centre, Department of Neurodegenerative Disease University College London Queen Square Institute of Neurology, University College London London United Kingdom.
Thomas D; Department of Brain Repair and Rehabilitation, University College London Queen Square Institute of Neurology University College London United Kingdom.; Leonard Wolfson Experimental Neurology Centre, University College London Queen Square Institute of Neurology University College London United Kingdom.
Zhang H; Department of Computer Science and Centre for Medical Image Computing University College London London United Kingdom.
De Vita E; Lysholm Department of Neuroradiology National Hospital for Neurology and Neurosurgery London United Kingdom.; Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences King's College London London United Kingdom.
Tabrizi SJ; University College London Huntington's Disease Centre, Department of Neurodegenerative Disease University College London Queen Square Institute of Neurology, University College London London United Kingdom.
Rees G; Wellcome Trust Centre for Neuroimaging, Institute of Neurology University College London London United Kingdom.
Scahill RI; University College London Huntington's Disease Centre, Department of Neurodegenerative Disease University College London Queen Square Institute of Neurology, University College London London United Kingdom.
Wild EJ; University College London Huntington's Disease Centre, Department of Neurodegenerative Disease University College London Queen Square Institute of Neurology, University College London London United Kingdom.
Pokaż więcej
Źródło:
Movement disorders clinical practice [Mov Disord Clin Pract] 2019 Nov 28; Vol. 7 (1), pp. 52-60. Date of Electronic Publication: 2019 Nov 28 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of inclined surfaces on gait variability and stability in unilateral lower limb amputees.
Autorzy:
Rodrigues FB; Bioengineering and Biomechanics Laboratory, Federal University of Goiás, Goiânia, 74.690-900, Brazil. .; State University of Goiás-Campus Trindade, Trindade, Goiás, 75.386-580, Brazil. .
Andrade AO; Centre for Innovation and Technology Assessment in Health (NIATS), Federal University of Uberlândia, Uberlândia, Brazil.
Vieira MF; Bioengineering and Biomechanics Laboratory, Federal University of Goiás, Goiânia, 74.690-900, Brazil.
Pokaż więcej
Źródło:
Medical & biological engineering & computing [Med Biol Eng Comput] 2019 Nov; Vol. 57 (11), pp. 2337-2346. Date of Electronic Publication: 2019 Sep 10.
Typ publikacji:
Journal Article
MeSH Terms:
Amputees*
Leg*
Gait/*physiology
Adult ; Artificial Limbs ; Case-Control Studies ; Exercise Test ; Female ; Humans ; Male ; Walking
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI.
Autorzy:
Rodrigues FB; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
Byrne LM; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
De Vita E; Neuroradiological Academic Unit, UCL Queen Square Institute of Neurology, University College London, London, UK.; Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Johnson EB; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
Hobbs NZ; Ixico Plc, London, UK.
Thornton JS; Neuroradiological Academic Unit, UCL Queen Square Institute of Neurology, University College London, London, UK.
Scahill RI; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
Wild EJ; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
Pokaż więcej
Źródło:
The European journal of neuroscience [Eur J Neurosci] 2019 Jun; Vol. 49 (12), pp. 1632-1639. Date of Electronic Publication: 2019 Feb 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Magnetic Resonance Imaging*
Cerebrospinal Fluid/*diagnostic imaging
Cerebrospinal Fluid/*physiology
Huntington Disease/*diagnostic imaging
Huntington Disease/*physiopathology
Cross-Sectional Studies ; Female ; Humans ; Hydrodynamics ; Male ; Middle Aged ; Pilot Projects ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of the Huntington's Disease like 2 and Huntington's Disease Clinical Phenotypes.
Autorzy:
Anderson DG; The University of the Witwatersrand Donald Gordon Medical Centre Neurology Johannesburg South Africa.; Division of Human Genetics National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, The University of the Witwatersrand Johannesburg South Africa.
Ferreira-Correia A; Department of Psychology School of Human and Community Development, University of the Witwatersrand. Johannesburg South Africa.
Rodrigues FB; UCL Huntington's Disease Centre University College London UK.; Clinical Pharmacology Unit Instituto de Medicina Molecular Portugal.; Laboratory of Clinical Pharmacology and Therapeutics University of Lisbon Portugal.
Aziz NA; German Center for Neurodegenerative Diseases (DZNE) Bonn Germany.
Carr J; Division of Neurology, Department of Medicine University of Stellenbosch Cape Town South Africa.
Wild EJ; UCL Huntington's Disease Centre University College London UK.
Margolis RL; Departments of Psychiatry and Neurology, Program in Cellular and Molecular Medicine Johns Hopkins University School of Medicine Baltimore MD USA.
Krause A; Division of Human Genetics National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, The University of the Witwatersrand Johannesburg South Africa.
Pokaż więcej
Źródło:
Movement disorders clinical practice [Mov Disord Clin Pract] 2019 Mar 12; Vol. 6 (4), pp. 302-311. Date of Electronic Publication: 2019 Mar 12 (Print Publication: 2019).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Huntington's Disease Clinical Trials Corner: January 2019.
Autorzy:
Rodrigues FB; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, UK.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, PT.; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, PT.
Quinn L; Department of Biobehavioral Sciences, Teachers College, Columbia University, USA.
Wild EJ; UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, UK.
Pokaż więcej
Źródło:
Journal of Huntington's disease [J Huntingtons Dis] 2019; Vol. 8 (1), pp. 115-125.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Clinical Trials as Topic*
Huntington Disease/*diagnosis
Huntington Disease/*therapy
Humans ; Longitudinal Studies ; Registries ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic review.
Autorzy:
Leal I; Department of Ophthalmology, Hospital de Santa Maria-CHLN, Lisbon Academic Medical Centre, Lisboa, Portugal.; Department of Ophthalmology, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.; Centro de Estudos das Ciências da Visão, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Rodrigues FB; Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Huntington's Disease Centre, University College London, London, UK.
Sousa DC; Department of Ophthalmology, Hospital de Santa Maria-CHLN, Lisbon Academic Medical Centre, Lisboa, Portugal.; Department of Ophthalmology, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.; Centro de Estudos das Ciências da Visão, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Romão VC; Department of Rheumatology, Hospital de Santa Maria-CHLN, Lisbon Academic Medical Centre, Lisbon, Portugal.; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Duarte GS; Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Carreño E; Clinical Research Unit, Bristol Eye Hospital NHS Foundation Trust, Bristol, UK.
Dick AD; Clinical Research Unit, Bristol Eye Hospital NHS Foundation Trust, Bristol, UK.; School of Clinical Sciences, Faculty of Medicine and Dentistry, University of Bristol, Bristol, UK.; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
Marques-Neves C; Department of Ophthalmology, Hospital de Santa Maria-CHLN, Lisbon Academic Medical Centre, Lisboa, Portugal.; Department of Ophthalmology, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.; Centro de Estudos das Ciências da Visão, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Costa J; Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Evidence Based Medicine Centre, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Portuguese Collaborating Centre of the Cochrane Iberoamerican Network, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Fonseca JE; Department of Rheumatology, Hospital de Santa Maria-CHLN, Lisbon Academic Medical Centre, Lisbon, Portugal.; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Pokaż więcej
Źródło:
Acta ophthalmologica [Acta Ophthalmol] 2018 Sep; Vol. 96 (6), pp. e665-e675. Date of Electronic Publication: 2018 Mar 25.
Typ publikacji:
Journal Article; Review; Systematic Review
MeSH Terms:
Immunosuppressive Agents/*administration & dosage
Tumor Necrosis Factor-alpha/*antagonists & inhibitors
Uveitis/*drug therapy
Adult ; Humans ; Intravitreal Injections ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations.
Autorzy:
Mestre TA; Parkinson's Disease and Movement Disorders Center, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute University of Ottawa Brain and Mind Research Institute Canada.
Busse M; Centre for Trials Research Cardiff University Wales UK.
Davis AM; Krembil Research Institute, University Health Network and Institute of Health Policy, Management and Evaluation and Rehabilitation Institute University of Toronto Canada.
Quinn L; Department of Biobehavioral Sciences, Teachers College Columbia University USA.
Rodrigues FB; Huntington's Disease Centre, Institute of Neurology University College London, UK, Clinical Pharmacology Unit, Instituto de Medicina Molecular Portugal.
Burgunder JM; Swiss HD Center, Neuro Zentrum Siloah and Department of Neurology University of Bern Switzerland.
Carlozzi NE; Department of Physical Medicine and Rehabilitation University of Michigan USA.
Walker F; Department of Neurology Wake Forest School of Medicine USA.
Ho AK; School of Psychology and Clinical Language Sciences University of Reading Reading UK.
Sampaio C; CHDI Foundation/management USA.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine University of Lisbon Portugal.
Goetz CG; Department of Neurological Sciences Rush University Medical Center Chicago USA.
Cubo E; Department of Neurology Hospital Universitário HermanosYagüe Burgos Spain.
Martinez-Martin P; National Center of Epidemiology and CIBERNED Carlos III Institute of Health Madrid Spain.
Stebbins GT; Department of Neurological Sciences Rush University Medical Center Chicago USA.
Pokaż więcej
Corporate Authors:
Members of the MDS Committee on Rating Scales Development
Źródło:
Movement disorders clinical practice [Mov Disord Clin Pract] 2018 May 09; Vol. 5 (4), pp. 361-372. Date of Electronic Publication: 2018 May 09 (Print Publication: 2018).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 35

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies